Drugs used for prostate cancer may not increase bleeding or clotting risks when used with blood thinners, thus providing ...
ETHealthworld.com brings latest quality of life news, views and updates from all top sources for the Indian Health industry.
The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst ...
Discover more about how nutrition and lifestyle interventions can improve the quality of life of patients with prostate ...
Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...
PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...
Sofetabart mipitecan (LY4170156), an investigational folate receptor alpha (FRα)-targeted antibody-drug conjugate (ADC), elicited strong antitumor activity in patients with recurrent ...
View Monte Rosa Therapeutics, Inc. GLUE stock quote prices, financial information, real-time forecasts, and company news from CNN.
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Analysis of a pre-screening platform for clinical trials in patients with prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results